Global Engage is pleased to announce the Probiotics Congress: Asia which will be held on 29 February - 1 March in Kuala Lumpur, Malaysia and will be co-located with the 2nd Microbiome R&D and Business Collaboration Congress: Asia. As consumers become increasingly conscious about their health and purchasing power increases across the Asia-Pacific region, greater focus has turned to preventative healthcare products. With increasing awareness of the benefits that “friendly” probiotic bacteria possess, the probiotic market is projected to reach $US 46.55 billion by 2020 with the Asia-Pacific market alone expected to grow at a CAGR of 8% from 2014-2019. Aside from traditional benefits in areas such as gastrointestinal disease, probiotics are being targeted at new areas such as inflammatory problems, allergy prevention, cholesterol reduction and more. Increased funding towards probiotic research, a focus on personalised nutrition, a greatly expanding market and increased scrutiny on health claim substantiation has led this to be one of the most exciting times for probiotic research in the region.Attracting over 150 attendees, this co-located congress will expand on our established microbiome series of events to explore the discovery and use of probiotics to treat and manage disease through a series of interactive presentations with leading academics and industry experts, panel discussions and an exhibition area allowing solution providers to showcase their products and services. We will look into the latest scientific findings as well as manufacturing protocols and regulations and how we can use probiotics to boost natural immunity and restore the microbiome.